https://www.thebodypro.com/article/peering-pipeline
    Sustiva is currently one of the most effective and commonly prescribed HIV meds, but that could change if newer drugs in its class (non-nucleosides) are approved.
    Share
    There are plans to combine rilpivirine with Viread and Emtriva in a single pill, creating a competitor for Atripla.
    Share

    Mark Milano

    ACRIA and GMHC